A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia

Name: A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia
Published: 2006
License: Public Domain

Novartis · 2006

ClinicalTrials.gov · Datasets · License: Public Domain · 2006

Open Source ↗

diabetes-mellitus type-2 type-2-diabetes

diabetes mellitus, type 2, type 2 diabetes, vildagliptin, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia

Related documents